Skip to main content
. 2000 Apr;99(4):615–624. doi: 10.1046/j.1365-2567.2000.00989.x

Figure 6.

Figure 6

Leishmania major-specific antibody (Ab) production in interleukin-12 (IL-12) gene-treated BALB/c mice infected with L. major. Sera was collected 5 weeks after L. major infection in gene-treated mice. Sera was tested for L. major-specific antibody: (a) IgG; (b) IgG2a; and (c) IgG1. Data shown represent the mean± SD for four mice. Results are representative of two independent experiments. *Signifies a statistically significant difference (P < 0·05) between the group treated with pCAGGS (Control) and that treated with pCAGGS-IL-12 (IL-12).